Immediate Impact
27 standout
Citing Papers
Epidemiology of metabolic dysfunction-associated steatotic liver disease
2024 Standout
NAFLD and NASH: etiology, targets and emerging therapies
2024 Standout
Works of Min Yi being referenced
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Min Yi | 30 | 12 | 75 | 58 | 39 | 31 | 287 | |
| Н. Д. Газатова | 17 | 3 | 88 | 74 | 19 | 34 | 295 | |
| Luying Huang | 28 | 52 | 62 | 54 | 18 | 24 | 325 | |
| Haiwei Li | 20 | 57 | 45 | 19 | 26 | 292 | ||
| Min Shao | 20 | 2 | 124 | 37 | 24 | 21 | 309 | |
| Liya Chen | 15 | 6 | 84 | 70 | 15 | 33 | 284 | |
| Dan Wu | 15 | 3 | 90 | 21 | 18 | 28 | 241 | |
| Xinjian Ye | 28 | 10 | 97 | 37 | 23 | 44 | 333 | |
| Laia Bertran | 6 | 49 | 87 | 34 | 29 | 194 | ||
| Xinyi Wang | 10 | 3 | 41 | 91 | 25 | 31 | 272 | |
| Yining Ding | 40 | 6 | 70 | 33 | 31 | 30 | 327 |
All Works
Loading papers...